Riskpilot← Back to searchSign inGet full accessMH-Saluspharma Ab
OYActiveY-tunnus 3261619-2Borgaregatan 7-1Retail sale of medical and orthopaedic goods · NACE 4774Est. 2022— employees
Revenue 2025
EUR 693K
-9% vs 2024
EBITDA margin
30.4%
-15% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
EUR 170K
-14% vs 2024
| Revenue | EUR 693K | -9% |
| EBITDA | EUR 210K | -15% |
| Net profit | EUR 170K | -14% |
| Total assets | EUR 715K | +20% |
| Equity | EUR 686K | +22% |
| Employees | — | — |
Legal name
MH-Saluspharma Ab
Y-tunnus number
3261619-2
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
17. tammikuuta 2022
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Bolagets verksamhet omfattar detalj- och partihandel, import, export och tillverkning av preparat och produkter, såsom naturkostprodukter, naturpreparat, kosmetika och kemikalievaror, som relaterar till hälsovård. Även konsultering, produktutveckling och utförande av marknadsföringstjänster i anslutning till läkemedels- och apoteksbranschen ingår i verksamheten samt hälso- och sjukvårdstjänster. Bolagets verksamhet är även att sköta juridiska ärenden. I bolagets verksamhet ingår även att äga och bedriva handel med värdepapper och bostads- och fastighetsaktiebolags aktier samt att äga, bedriva handel och hyra ut fastigheter och lägenheter.
Address
Borgaregatan 7-1
Phone
+3580405650819
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 693 | 894 | 766 | 693 |
| Staff expenses | — | −0 | −0 | −0 |
| EBITDA | 225 | 285 | 247 | 210 |
| Depreciation & amort. | — | −0 | −0 | −0 |
| EBIT | 225 | 285 | 247 | 210 |
| Net financials | −0 | 0 | 1 | 2 |
| Profit before tax | 225 | 285 | 248 | 213 |
| Tax | 45 | 57 | 50 | 43 |
| Net profit | 180 | 228 | 198 | 170 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 262 | 416 | 598 | 715 |
| Equity | 180 | 394 | 561 | 686 |
| Long-term debt | — | 0 | 0 | 0 |
| Short-term debt | 81 | 22 | 37 | 29 |
| Total debt | 81 | 22 | 37 | 29 |
EBITDA margin
30.4%
This company
15.8%
Market median
+92% vs market
20222025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20222025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20222025
Net profit margin
24.6%
This company
8.1%
Market median
+204% vs market
20222025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20222025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SR | Audit | 2022 | — | — |
MC Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
TE Deputy auditor | Deputy auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairperson | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MH-Saluspharma Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Rolf Axel Wiklund | Audit | 0 companies |
| Mona Christina Heikfolk | Chief Executive Officer | 0 companies |
| Tony Erik Hämäläinen | Deputy auditor | 0 companies |
| Markus Karl Wilhelm Heikfolk | Board of Directors | 0 companies |
| Simon Sebastian Heikfolk | Board of Directors | 0 companies |
| Sara Irene Heikfolk | Board of Directors | 0 companies |
| Johan Anders Heikfolk | Chairperson | 0 companies |